Stocks
ZIVO Bioscience, Inc.ZIVO
OIDHealthcareBiotechnology$6.50
Price as of · delayed, not real-time
A clinical-stage biotech developing a proprietary immunomodulatory compound, ZIVO-B, for inflammatory and infectious diseases, including a lead program in bovine mastitis. The company also explores agricultural applications for its technology platform. Investors track ZIVO for its progress toward FDA approval and potential commercialization in animal health.
52W Range: $1.11-$17.50
Congressional Interest in ZIVO Bioscience, Inc. (ZIVO)
No congressional trades have been disclosed for ZIVO Bioscience, Inc. (ZIVO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ZIVO?
No congressional trades found for this stock.